# MBD1

## Overview
MBD1 (methyl-CpG binding domain protein 1) is a gene that encodes a protein of the same name, which plays a pivotal role in epigenetic regulation by binding to methylated DNA. The protein is categorized as a transcriptional regulator due to its involvement in modulating gene expression through interactions with chromatin and other regulatory proteins. MBD1 contains a conserved methyl-CpG binding domain (MBD) that facilitates its binding to methylated CpG islands, leading to transcriptional repression of target genes. Additionally, the protein features CXXC-type zinc finger domains and a transcriptional repression domain (TRD), which enable it to interact with both methylated and unmethylated DNA and recruit various transcriptional repressor complexes. MBD1 is implicated in critical biological processes, including neurogenesis and genome stability, and its dysregulation is associated with several diseases, such as cancer and neurological disorders (Fujita1999MethylationMediated; Fujita2000Mechanism; Li2015An).

## Structure
MBD1 (methyl-CpG binding domain protein 1) is a protein characterized by its ability to bind methylated DNA, playing a crucial role in transcriptional regulation. The protein structure of MBD1 includes a conserved methyl-CpG binding domain (MBD) at its N-terminus, which is responsible for recognizing and binding to methylated DNA. This domain adopts a novel α-β sandwich structure, with specific residues such as Arg22, Arg30, Arg44, Tyr34, and Asp32 being critical for DNA binding (Clouaire2010Recruitment; Fujita2000Mechanism).

MBD1 also contains several CXXC-type zinc finger domains, which vary among its isoforms due to alternative splicing. The CXXC3 domain, present in some isoforms like MBD1v1, allows binding to both methylated and unmethylated DNA, contributing to its role in transcriptional regulation (Fujita2000Mechanism; Li2015An). The C-terminal transcriptional repression domain (TRD) is involved in interactions with other proteins, such as MCAF1 and MCAF2, and is essential for transcriptional repression (Ichimura2005Transcriptional).

MBD1 has multiple isoforms, including MBD1v1, MBD1v2, MBD1v3, and MBD1v4, which differ in the presence of CXXC domains and their ability to repress transcription from methylated and unmethylated promoters (Fujita2000Mechanism). These structural features enable MBD1 to participate in various epigenetic regulatory processes.

## Function
MBD1 (methyl-CpG binding domain protein 1) is a crucial epigenetic regulator involved in transcriptional repression through its ability to bind methylated DNA. It plays a significant role in maintaining genome stability and regulating gene expression in healthy human cells. MBD1 is predominantly localized in euchromatic regions of the nucleus, where it binds to methylated CpG islands, leading to transcriptional silencing of associated genes (Fujita1999MethylationMediated).

The protein contains a methyl-CpG binding domain (MBD) and cysteine-rich CXXC domains, which allow it to interact with both methylated and unmethylated DNA. This dual binding capability enables MBD1 to modulate gene expression by forming complexes with other proteins, such as histone methylases and deacetylases, to alter chromatin structure and repress transcription (Fujita2000Mechanism; Fujita2003MethylCpG).

MBD1 is also involved in neurogenesis, with high expression levels in neural stem cells and neurons. It regulates genes crucial for neuronal differentiation and proliferation, such as the basic fibroblast growth factor 2 (Fgf-2), by binding to their promoters and inducing hypermethylation (Li2015An). Through these molecular activities, MBD1 contributes to normal brain development and function.

## Clinical Significance
Mutations and altered expression of the MBD1 gene have been implicated in various diseases, particularly in cancer and neurological disorders. In cancer, MBD1 plays a dual role. It can act as a tumor suppressor, as suggested by its location on chromosome 18q21, a region frequently exhibiting loss of heterozygosity in cancers like colon and lung cancer (Li2015An). However, MBD1 also represses tumor suppressor genes by binding to methylated CpG islands, potentially promoting tumorigenesis in certain contexts, such as pancreatic cancer (Li2015An). In acute promyelocytic leukemia, MBD1 is involved in gene silencing through its interaction with the PML-RARα fusion protein, contributing to the disease's progression (Villa2006The).

In the nervous system, MBD1 is crucial for neurogenesis and hippocampal function. MBD1 knockout mice exhibit reduced neurogenesis and impaired spatial learning, indicating its importance in cognitive processes (Zhao2003Mice). MBD1 is also linked to autism spectrum disorders through its regulation of the serotonin receptor Htr2c (Li2015An). Additionally, MBD1 contributes to the regulation of pain pathways, with its deficiency leading to altered pain responses (Mo2018MBD1). These findings highlight MBD1's significant role in both cancer and neurological conditions.

## Interactions
MBD1 (methyl-CpG binding domain protein 1) is involved in various interactions with proteins and nucleic acids, playing a significant role in transcriptional repression and chromatin remodeling. MBD1 binds to methylated DNA through its methyl-CpG binding domain (MBD), influencing gene expression by recruiting transcriptional repressor complexes. It interacts with histone deacetylases (HDAC1 and HDAC2) indirectly via Suv39h1, a transcriptional corepressor, which enhances MBD1-mediated transcriptional repression (Fujita2003MethylCpG).

MBD1 also forms complexes with the MBD1-containing chromatin-associated factor (MCAF), which interacts with its transcriptional repression domain (TRD) to mediate transcriptional repression independently of histone deacetylation (Fujita2003MCAF). The TRD of MBD1 is intrinsically disordered, allowing it to interact selectively with various proteins, including HDAC3, the PML-RARa oncoprotein, and proteins from the MCAF family (Hameed2014Transcriptional).

Additionally, MBD1 interacts with the Suv39h1-HP1 heterochromatic complex, linking DNA methylation to histone modifications, which results in gene inactivation (Fujita2003MethylCpG). These interactions highlight MBD1's role as a critical connector in epigenetic regulation, influencing both gene expression and chromatin structure.


## References


[1. (Villa2006The) Raffaella Villa, Lluis Morey, Veronica A. Raker, Marcus Buschbeck, Arantxa Gutierrez, Francesca De Santis, Massimo Corsaro, Florencio Varas, Daniela Bossi, Saverio Minucci, Pier Giuseppe Pelicci, and Luciano Di Croce. The methyl-cpg binding protein mbd1 is required for pml-rarα function. Proceedings of the National Academy of Sciences, 103(5):1400–1405, January 2006. URL: http://dx.doi.org/10.1073/pnas.0509343103, doi:10.1073/pnas.0509343103. This article has 85 citations.](https://doi.org/10.1073/pnas.0509343103)

[2. (Ichimura2005Transcriptional) Takaya Ichimura, Sugiko Watanabe, Yasuo Sakamoto, Takahiro Aoto, Naoyuki Fujita, and Mitsuyoshi Nakao. Transcriptional repression and heterochromatin formation by mbd1 and mcaf/am family proteins. Journal of Biological Chemistry, 280(14):13928–13935, April 2005. URL: http://dx.doi.org/10.1074/jbc.m413654200, doi:10.1074/jbc.m413654200. This article has 101 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.m413654200)

[3. (Zhao2003Mice) Xinyu Zhao, Tetsuya Ueba, Brian R. Christie, Basam Barkho, Michael J. McConnell, Kinichi Nakashima, Edward S. Lein, Brennan D. Eadie, Andrew R. Willhoite, Alysson R. Muotri, Robert G. Summers, Jerold Chun, Kuo-Fen Lee, and Fred H. Gage. Mice lacking methyl-cpg binding protein 1 have deficits in adult neurogenesis and hippocampal function. Proceedings of the National Academy of Sciences, 100(11):6777–6782, May 2003. URL: http://dx.doi.org/10.1073/pnas.1131928100, doi:10.1073/pnas.1131928100. This article has 306 citations.](https://doi.org/10.1073/pnas.1131928100)

[4. (Fujita2000Mechanism) Naoyuki Fujita, Nobuya Shimotake, Izuru Ohki, Tsutomu Chiba, Hideyuki Saya, Masahiro Shirakawa, and Mitsuyoshi Nakao. Mechanism of transcriptional regulation by methyl-cpg binding protein mbd1. Molecular and Cellular Biology, 20(14):5107–5118, July 2000. URL: http://dx.doi.org/10.1128/MCB.20.14.5107-5118.2000, doi:10.1128/mcb.20.14.5107-5118.2000. This article has 195 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1128/MCB.20.14.5107-5118.2000)

[5. (Fujita2003MCAF) Naoyuki Fujita, Sugiko Watanabe, Takaya Ichimura, Yoshiaki Ohkuma, Tsutomu Chiba, Hideyuki Saya, and Mitsuyoshi Nakao. Mcaf mediates mbd1-dependent transcriptional repression. Molecular and Cellular Biology, 23(8):2834–2843, April 2003. URL: http://dx.doi.org/10.1128/mcb.23.8.2834-2843.2003, doi:10.1128/mcb.23.8.2834-2843.2003. This article has 70 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1128/mcb.23.8.2834-2843.2003)

[6. (Clouaire2010Recruitment) Thomas Clouaire, Jose Ignacio de las Heras, Cara Merusi, and Irina Stancheva. Recruitment of mbd1 to target genes requires sequence-specific interaction of the mbd domain with methylated dna. Nucleic Acids Research, 38(14):4620–4634, April 2010. URL: http://dx.doi.org/10.1093/nar/gkq228, doi:10.1093/nar/gkq228. This article has 69 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1093/nar/gkq228)

[7. (Mo2018MBD1) Kai Mo, Shaogen Wu, Xiyao Gu, Ming Xiong, Weihua Cai, Fidelis E. Atianjoh, Emily E. Jobe, Xinyu Zhao, Wei-Feng Tu, and Yuan-Xiang Tao. Mbd1 contributes to the genesis of acute pain and neuropathic pain by epigenetic silencing ofoprm1andkcna2genes in primary sensory neurons. The Journal of Neuroscience, 38(46):9883–9899, September 2018. URL: http://dx.doi.org/10.1523/JNEUROSCI.0880-18.2018, doi:10.1523/jneurosci.0880-18.2018. This article has 52 citations.](https://doi.org/10.1523/JNEUROSCI.0880-18.2018)

[8. (Fujita2003MethylCpG) Naoyuki Fujita, Sugiko Watanabe, Takaya Ichimura, Shu Tsuruzoe, Yoichi Shinkai, Makoto Tachibana, Tsutomu Chiba, and Mitsuyoshi Nakao. Methyl-cpg binding domain 1 (mbd1) interacts with the suv39h1-hp1 heterochromatic complex for dna methylation-based transcriptional repression. Journal of Biological Chemistry, 278(26):24132–24138, June 2003. URL: http://dx.doi.org/10.1074/jbc.M302283200, doi:10.1074/jbc.m302283200. This article has 361 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.M302283200)

[9. (Li2015An) Lu Li, Bi-Feng Chen, and Wai-Yee Chan. An epigenetic regulator: methyl-cpg-binding domain protein 1 (mbd1). International Journal of Molecular Sciences, 16(3):5125–5140, March 2015. URL: http://dx.doi.org/10.3390/ijms16035125, doi:10.3390/ijms16035125. This article has 35 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms16035125)

[10. (Fujita1999MethylationMediated) Naoyuki Fujita, Shin-ichiro Takebayashi, Katsuzumi Okumura, Shinichi Kudo, Tsutomu Chiba, Hideyuki Saya, and Mitsuyoshi Nakao. Methylation-mediated transcriptional silencing in euchromatin by methyl-cpg binding protein mbd1 isoforms. Molecular and Cellular Biology, 19(9):6415–6426, September 1999. URL: http://dx.doi.org/10.1128/mcb.19.9.6415, doi:10.1128/mcb.19.9.6415. This article has 149 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1128/mcb.19.9.6415)

[11. (Hameed2014Transcriptional) Umar Farook Shahul Hameed, Jackwee Lim, Qian Zhang, Mariusz A. Wasik, Daiwen Yang, and Kunchithapadam Swaminathan. Transcriptional repressor domain of mbd1 is intrinsically disordered and interacts with its binding partners in a selective manner. Scientific Reports, May 2014. URL: http://dx.doi.org/10.1038/srep04896, doi:10.1038/srep04896. This article has 13 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/srep04896)